Titre : Anthropologie médicale

Anthropologie médicale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Systemic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anthropologie médicale : Questions médicales les plus fréquentes", "headline": "Anthropologie médicale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anthropologie médicale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-29", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anthropologie médicale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anthropologie", "url": "https://questionsmedicales.fr/mesh/D000883", "about": { "@type": "MedicalCondition", "name": "Anthropologie", "code": { "@type": "MedicalCode", "code": "D000883", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076" } } }, "about": { "@type": "MedicalCondition", "name": "Anthropologie médicale", "alternateName": "Anthropology, Medical", "code": { "@type": "MedicalCode", "code": "D060432", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Gemmae M Fix", "url": "https://questionsmedicales.fr/author/Gemmae%20M%20Fix", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "P Charlier", "url": "https://questionsmedicales.fr/author/P%20Charlier", "affiliation": { "@type": "Organization", "name": "Laboratoire anthropologie archéologie biologie (LAAB), Université Paris-Saclay & Musée du quai Branly - Jacques Chirac, 2 avenue de la source de la Bièvre, 78180 Montigny-Le-Bretonneux, France." } }, { "@type": "Person", "name": "Nicholas V Passalacqua", "url": "https://questionsmedicales.fr/author/Nicholas%20V%20Passalacqua", "affiliation": { "@type": "Organization", "name": "Department of Anthropology and Sociology, Western Carolina University, Cullowhee, NC 28723, USA." } }, { "@type": "Person", "name": "Marin A Pilloud", "url": "https://questionsmedicales.fr/author/Marin%20A%20Pilloud", "affiliation": { "@type": "Organization", "name": "Department of Anthropology, University of Nevada, Reno, NV 89557, USA." } }, { "@type": "Person", "name": "Zuzana Obertová", "url": "https://questionsmedicales.fr/author/Zuzana%20Obertov%C3%A1", "affiliation": { "@type": "Organization", "name": "Forensic Science Institute Zürich, Zürich, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.", "datePublished": "2024-08-23", "url": "https://questionsmedicales.fr/article/39273131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25179182" } }, { "@type": "ScholarlyArticle", "name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36163292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.disamonth.2022.101468" } }, { "@type": "ScholarlyArticle", "name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chest.2022.09.044" } }, { "@type": "ScholarlyArticle", "name": "Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/35931315", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.autrev.2022.103167" } }, { "@type": "ScholarlyArticle", "name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36082759", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/BOR.0000000000000904" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences sociales", "item": "https://questionsmedicales.fr/mesh/D012942" }, { "@type": "ListItem", "position": 3, "name": "Anthropologie", "item": "https://questionsmedicales.fr/mesh/D000883" }, { "@type": "ListItem", "position": 4, "name": "Anthropologie médicale", "item": "https://questionsmedicales.fr/mesh/D060432" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anthropologie médicale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anthropologie médicale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anthropologie médicale", "description": "Comment l'anthropologie médicale aide-t-elle au diagnostic ?\nQuels outils utilise l'anthropologie médicale pour le diagnostic ?\nQuel rôle joue le contexte culturel dans le diagnostic ?\nComment les pratiques traditionnelles influencent-elles le diagnostic ?\nL'anthropologie médicale peut-elle identifier des biais dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D060432?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anthropologie médicale", "description": "Comment les symptômes sont-ils perçus différemment selon les cultures ?\nQuels symptômes sont souvent minimisés dans certaines cultures ?\nLes symptômes peuvent-ils varier selon le sexe ?\nComment les croyances culturelles affectent-elles les symptômes ?\nLes symptômes psychosomatiques sont-ils reconnus universellement ?", "url": "https://questionsmedicales.fr/mesh/D060432?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anthropologie médicale", "description": "Comment l'anthropologie médicale contribue-t-elle à la prévention ?\nQuels facteurs culturels influencent la prévention des maladies ?\nLes campagnes de prévention doivent-elles être adaptées culturellement ?\nComment les rituels culturels peuvent-ils aider à la prévention ?\nLes croyances sur la maladie affectent-elles la prévention ?", "url": "https://questionsmedicales.fr/mesh/D060432?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anthropologie médicale", "description": "Comment l'anthropologie médicale influence-t-elle les traitements ?\nQuels traitements traditionnels sont souvent utilisés ?\nLes traitements varient-ils selon les cultures ?\nComment les praticiens intègrent-ils l'anthropologie dans les traitements ?\nLes traitements alternatifs sont-ils acceptés dans toutes les cultures ?", "url": "https://questionsmedicales.fr/mesh/D060432?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anthropologie médicale", "description": "Quelles complications peuvent survenir en raison de croyances culturelles ?\nComment les complications sont-elles perçues différemment ?\nLes complications psychosociales sont-elles reconnues dans toutes les cultures ?\nComment l'anthropologie médicale aide-t-elle à gérer les complications ?\nLes complications peuvent-elles être évitées par des interventions culturelles ?", "url": "https://questionsmedicales.fr/mesh/D060432?mesh_terms=Scleroderma,+Systemic&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anthropologie médicale", "description": "Quels facteurs culturels sont des risques pour la santé ?\nComment les inégalités sociales influencent-elles les risques ?\nLes croyances religieuses affectent-elles les facteurs de risque ?\nComment l'anthropologie médicale identifie-t-elle les facteurs de risque ?\nLes facteurs de risque varient-ils selon les populations ?", "url": "https://questionsmedicales.fr/mesh/D060432?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment l'anthropologie médicale aide-t-elle au diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de comprendre les croyances culturelles influençant la perception de la maladie." } }, { "@type": "Question", "name": "Quels outils utilise l'anthropologie médicale pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des enquêtes ethnographiques et des études de cas sont souvent utilisés." } }, { "@type": "Question", "name": "Quel rôle joue le contexte culturel dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le contexte culturel peut modifier les symptômes rapportés et leur interprétation." } }, { "@type": "Question", "name": "Comment les pratiques traditionnelles influencent-elles le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent mener à des interprétations différentes des maladies et des traitements." } }, { "@type": "Question", "name": "L'anthropologie médicale peut-elle identifier des biais dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle met en lumière les biais culturels et sociaux qui affectent le diagnostic." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils perçus différemment selon les cultures ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent être interprétés différemment selon les croyances culturelles." } }, { "@type": "Question", "name": "Quels symptômes sont souvent minimisés dans certaines cultures ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la douleur émotionnelle peuvent être sous-estimés dans certaines cultures." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon le sexe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les attentes culturelles peuvent influencer l'expression des symptômes selon le sexe." } }, { "@type": "Question", "name": "Comment les croyances culturelles affectent-elles les symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent influencer la manière dont les individus expriment et rapportent leurs symptômes." } }, { "@type": "Question", "name": "Les symptômes psychosomatiques sont-ils reconnus universellement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur reconnaissance varie selon les contextes culturels et médicaux." } }, { "@type": "Question", "name": "Comment l'anthropologie médicale contribue-t-elle à la prévention ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elle identifie les comportements culturels qui influencent la santé et la prévention des maladies." } }, { "@type": "Question", "name": "Quels facteurs culturels influencent la prévention des maladies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les croyances, les traditions et les pratiques sociales jouent un rôle clé dans la prévention." } }, { "@type": "Question", "name": "Les campagnes de prévention doivent-elles être adaptées culturellement ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'adaptation culturelle augmente l'efficacité des campagnes de prévention." } }, { "@type": "Question", "name": "Comment les rituels culturels peuvent-ils aider à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent renforcer les comportements de santé et promouvoir des pratiques préventives." } }, { "@type": "Question", "name": "Les croyances sur la maladie affectent-elles la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les croyances peuvent influencer l'engagement dans des comportements préventifs." } }, { "@type": "Question", "name": "Comment l'anthropologie médicale influence-t-elle les traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à adapter les traitements aux croyances et pratiques culturelles des patients." } }, { "@type": "Question", "name": "Quels traitements traditionnels sont souvent utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des remèdes à base de plantes et des rituels spirituels sont courants dans de nombreuses cultures." } }, { "@type": "Question", "name": "Les traitements varient-ils selon les cultures ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les approches de traitement peuvent différer considérablement d'une culture à l'autre." } }, { "@type": "Question", "name": "Comment les praticiens intègrent-ils l'anthropologie dans les traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils utilisent des connaissances culturelles pour améliorer l'adhésion et l'efficacité des traitements." } }, { "@type": "Question", "name": "Les traitements alternatifs sont-ils acceptés dans toutes les cultures ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur acceptation varie selon les croyances et les systèmes de santé locaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en raison de croyances culturelles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent survenir si les patients évitent les soins médicaux en raison de leurs croyances." } }, { "@type": "Question", "name": "Comment les complications sont-elles perçues différemment ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent être interprétées différemment selon les contextes culturels et médicaux." } }, { "@type": "Question", "name": "Les complications psychosociales sont-elles reconnues dans toutes les cultures ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur reconnaissance et leur traitement varient selon les cultures." } }, { "@type": "Question", "name": "Comment l'anthropologie médicale aide-t-elle à gérer les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle fournit des perspectives culturelles pour mieux comprendre et traiter les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées par des interventions culturelles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions adaptées culturellement peuvent réduire le risque de complications." } }, { "@type": "Question", "name": "Quels facteurs culturels sont des risques pour la santé ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des pratiques culturelles comme le tabagisme ou l'alimentation peuvent augmenter les risques." } }, { "@type": "Question", "name": "Comment les inégalités sociales influencent-elles les risques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les inégalités sociales peuvent exacerber les risques de maladies dans certaines populations." } }, { "@type": "Question", "name": "Les croyances religieuses affectent-elles les facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines croyances peuvent influencer les comportements de santé et les risques associés." } }, { "@type": "Question", "name": "Comment l'anthropologie médicale identifie-t-elle les facteurs de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Elle utilise des études ethnographiques pour comprendre les comportements et les risques associés." } }, { "@type": "Question", "name": "Les facteurs de risque varient-ils selon les populations ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les facteurs de risque peuvent varier considérablement d'une population à l'autre." } } ] } ] }

Sources (10000 au total)

Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.

Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort.... Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?... We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II... In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529... The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with... Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi... Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0... Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....

Scleroderma autoantibodies in guiding monitoring and treatment decisions.

One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia... There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows... ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome.

The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...

Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study.

People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe... The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys... Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by... People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...

[Autoimmune and inflammatory pathologies associated with systemic scleroderma: Clinical, serological and prognostic profiles. Bi-centric retrospective series in the PACA region].

Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc... We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul... The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv... SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...

Juvenile and adult-onset scleroderma: Different clinical phenotypes.

Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare... A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab... A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo... Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....